Drug Cystic Fibrosis

Kalydeco

Payments companies reported to CMS as associated with Kalydeco. "Associated with" is CMS's wording: it links a payment to a product without saying the money was spent on it.

$19Kassociated payments (2023-2025)
25clinicians with associated payments
2companies reporting

By year

2023 $1,325
2024 $12K
2025 $6,009

Payments reported as associated with Kalydeco, per program year, as reported to CMS.

Who makes it

Specialties most often involved

Critical Care Medicine (Internal Medicine) $11K
Pediatric Pulmonology $4,872
Pediatrics $3,196
Pulmonary Disease $396
Nurse Practitioner $125
Medical $125

Where the associated payments went, by the receiving clinician's specialty.

Clinicians most associated with Kalydeco

These are the largest totals companies reported as associated with Kalydeco. They are typically speaking or consulting arrangements, which companies must report by law; appearing here is not evidence of anything improper.

ClinicianLocationSpecialtyAssociated payments (2023-2025)
George Solomon Birmingham, AL Critical Care Medicine (Internal Medicine) $10,485.00
Preeti Sharma New Bedford, MA Pediatrics $2,440.00
Ryan Thomas Lansing, MI Pediatric Pulmonology $1,470.00
Christopher Siracusa Cincinnati, OH Pediatric Pulmonology $1,282.50
Scott Bickel Louisville, KY Pediatric Pulmonology $860.00
Kate Powers Albany, NY Pediatrics $735.00
Ashley Chadha Charlotte, NC Pediatric Pulmonology $610.00
Floyd Livingston Orlando, FL Pediatric Pulmonology $125.00
Luke Noronha Santa Barbara, CA Pediatric Pulmonology $125.00
Lauren Greenawald Camden, NJ Pediatric Pulmonology $125.00

Prescribed Kalydeco?

See what its makers reported for your doctor. Two steps, private, no account.

Check my doctor

Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.